4:53 PM
 | 
Sep 20, 2018
 |  BC Extra  |  Financial News

First-day pop for Y-mAbs after upsized $96M IPO

Editor's Note: This article was updated on Sep 21, 2018 at 8:28 AM PDT

Cancer company Y-mAbs Therapeutics Inc. (NASDAQ:YMAB) gained $8 (50%) to $24 on Friday after raising $96 million through the sale of 6 million shares at $16 in an IPO. BofA Merrill Lynch,...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >